Saturday 17 October 2026
Export AHG’s income statement to Excel — free account
Akso Health Group Sponsored ADR
AHG Healthcare Medical Distribution
Akso Health Group Sponsored ADR’s revenue for fiscal 2026 (year ended March 2026) was $13.8 million, down 6.40% from fiscal 2025.
1.35
0.00
0.00%
Follow AHG
| Older periods | Mar '23 | Sep '23 | Sep '24 | Sep '25 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(139.96%) | (99.22%) | 0.00% | 0.00% | |
| (69.78%) | (49.98%) | 0.00% | 0.00% | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
0.00% | (231.55%) | 0.00% | 0.00% | |
Average Days of Receivables |
0.00 | 105.61 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
(11.88) | (12.44) | 13.50 | (160.20) | |
Capital Expenditures |
— | — | (1.59) | (177.19) | |
| Other line items | |||||
Cash ROIC |
(71.34%) | (85.51%) | 4.55% | (76.49%) | |
Accounts Receivable Turnover |
0.00 | 1.57 | 0.00 | 0.00 | |
Days of Inventory on Hand |
— | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | — | — | |
Research and Development Expense of Revenue |
0.00% | 0.00% | — | — | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | — | — | |
Share Based Compensation of Revenue |
0.00% | 0.00% | — | — | |
Operating CF/Net income |
0.65 | 1.01 | 0.00 | 0.00 | |
Depreciation/Fixed assets |
— | — | 1.44 | 88.94 | |
Capex/Depreciation |
— | — | (9.70) | (129.37) | |
Revenue per Share |
0.00 | 0.00 | — | — | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates